PHARMACOLOGICAL STUDY OF HYDROXY BIS-[2-(P-CHLOROPHENOXY)-ISOBUTYRIC ACID] ALUMINIUM
[摘要] References(25)Cited-By(1)The hypolipidemic effect of alfibrate has been studied in normocholesterolemic rats with clofibrate as a reference. At the dosage of 150 mg/kg, 29% increase of liver weight was observed in the alfibrate group and 87% increase in the clofibrate group. Daily administration of alfibrate (150 mg/kg) produced a significant decrease in serum cholesterol (5%) and triglycerides (15%), and liver cholesterol (12%) and triglycerides (23%) with no change in phospholipids and free fatty acids. Like clofibrate, alfibrate exerted a greater effect on lowering the triglyceride level than cholesterol in normocholesterolemic rats. The liver glycogen concentration and glucose tolerance in the alfibrate group were similar to that of control.
[发布日期] [发布机构]
[效力级别] [学科分类] 药理学
[关键词] [时效性]